Provided by Tiger Trade Technology Pte. Ltd.

TransMedics Group, Inc.

78.00
+1.712.24%
Post-market: 78.000.00000.00%16:07 EDT
Volume:1.21M
Turnover:93.52M
Market Cap:2.69B
PE:17.47
High:79.28
Open:75.20
Low:74.98
Close:76.29
52wk High:156.00
52wk Low:60.11
Shares:34.54M
Float Shares:33.28M
Volume Ratio:1.51
T/O Rate:3.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.47
EPS(LYR):4.87
ROE:45.22%
ROA:5.19%
PB:5.45
PE(LYR):16.02

Loading ...

Jun 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 21, 2026

Major Issues Report

Form 8-K - Current report
May 06, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2026

Major Issues Report

Form 8-K - Current report
Apr 30, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 29, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Mar 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 27, 2026

Major Issues Report

Form 8-K - Current report
Feb 25, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2026

Major Issues Report

Form 8-K - Current report
Feb 05, 2026

Major Issues Report

Form 8-K - Current report
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Dec 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 26, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 29, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 29, 2025

Major Issues Report

Form 8-K - Current report
Oct 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 06, 2025

Major Issues Report

Form 8-K - Current report